EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 2013-33100010
MFR#: 3310-0010
GSP Neonatal G6PD kits are intended for the semi-quantitative determination of glucose-6-phosphate dehydrogenase (G6PD) concentrations in blood specimens collected onto filter paper, as an aid in screening newborns for G6PD deficiency. This kit is
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
GSP Neonatal Phenylalanine kit
|
Phenylketonuria (PKU) is a disorder of amino acid metabolism with reported incidence ranging from 1 in 19,000 to 1 in 13,500 newborn infants*. It is caused by an inability to convert phenylalanine to tyrosine due to deficient activity of the enzyme, | 2013-33080010 | EA | |
GSP Neonatal IRT kit
|
The GSP Neonatal IRT assay allows the quantitative determination of IRT from dried blood spot specimens, and is intended as an aid in screening for cystic fibrosis. The diagnosis of cystic fibrosis is often based on the symptoms, which may cause co | 2013-3306001U | EA | |
GSP Neonatal Biotinidase kit
|
The GSP Neonatal Biotinidase assay is intended for the quantitative determination of biotinidase activity in blood specimens dried on filter paper as an aid in screening newborns for biotinidase deficiency by using the GSP instrument. The incidence | 2013-3307001U | EA | |
GSP Neonatal hTSH kit
|
The Revvity GSP Neonatal hTSH assay is used with dried blood spot specimens as an aid in screening newborns for congenital hypothyroidism. Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in ad | 2013-3301001U | EA | |
GSP Neonatal IRT kit
|
The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome. The amount of the pan | 2013-33060010 | EA |